These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 21344794
1. Analysis of the plasma concentration of tacrolimus: a useful method for distinguishing falsely elevated tacrolimus concentrations reported by the ACMIA. Yamaoka M, Kawamura R, Shioda Y, Ogawa N, Koyama I, Saitoh T, Ikebuchi K. Rinsho Byori; 2010 Dec; 58(12):1188-92. PubMed ID: 21344794 [Abstract] [Full Text] [Related]
2. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report. Toraishi T, Takeuchi H, Nakamura Y, Konno O, Yokoyama T, Iwamoto H, Hama K, Hirano T, Unezaki S, Okuyama K, Shimazu M. Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597 [Abstract] [Full Text] [Related]
3. Falsely elevated tacrolimus concentrations measured using the ACMIA method due to circulating endogenous antibodies in a kidney transplant recipient. D'Alessandro M, Mariani P, Mennini G, Severi D, Berloco P, Bachetoni A. Clin Chim Acta; 2011 Jan 30; 412(3-4):245-8. PubMed ID: 21059349 [Abstract] [Full Text] [Related]
4. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards. Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, Kamar N. Transpl Int; 2010 Feb 30; 23(2):227-30. PubMed ID: 19761555 [Abstract] [Full Text] [Related]
5. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients. Bazin C, Guinedor A, Barau C, Gozalo C, Grimbert P, Duvoux C, Furlan V, Massias L, Hulin A. J Pharm Biomed Anal; 2010 Dec 01; 53(4):997-1002. PubMed ID: 20674215 [Abstract] [Full Text] [Related]
6. Falsely elevated whole blood tacrolimus concentrations due to interference in an affinity column-mediated immunoassay method on Xpand dimension. Barau C, Frangie C, Goujard C, Tribut O, Parant F, Taburet AM, Durrbach A, Furlan V. Ther Drug Monit; 2009 Apr 01; 31(2):267-8. PubMed ID: 19214146 [Abstract] [Full Text] [Related]
7. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation. Tempestilli M, Di Stasio E, Basile MR, Elisei F, Antonini M, Ettorre GM, Iappelli M, Pucillo LP. Ther Drug Monit; 2013 Feb 01; 35(1):96-100. PubMed ID: 23191996 [Abstract] [Full Text] [Related]
8. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay? Ju MK, Chang HK, Kim HJ, Huh KH, Ahn HJ, Kim MS, Kim SI, Kim YS. Transplant Proc; 2008 Dec 01; 40(10):3673-8. PubMed ID: 19100463 [Abstract] [Full Text] [Related]
9. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus]. Chung JW, An D, Song J, Chung HJ, Park HI, Lee W, Chun S, Min WK. Korean J Lab Med; 2009 Oct 01; 29(5):415-22. PubMed ID: 19893350 [Abstract] [Full Text] [Related]
10. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H. Exp Clin Transplant; 2014 Oct 01; 12(5):474-8. PubMed ID: 24206050 [Abstract] [Full Text] [Related]
12. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Hermida J, Tutor JC. Ther Drug Monit; 2009 Apr 01; 31(2):269-72. PubMed ID: 19258927 [Abstract] [Full Text] [Related]
13. False Elevation of the Blood Tacrolimus Concentration, as Assessed by an Affinity Column-mediated Immunoassay (ACMIA), Led to Acute T Cell-mediated Rejection after Kidney Transplantation. Kono M, Hasegawa J, Ogawa H, Yoshikawa K, Ishiwatari A, Wakai S, Tanabe K, Shirakawa H. Intern Med; 2018 May 01; 57(9):1265-1268. PubMed ID: 29279473 [Abstract] [Full Text] [Related]
14. Rheumatoid factor interference in a tacrolimus immunoassay. Barceló Martín B, Marquet P, Ferrer JM, Castanyer Puig B, Barcelo Bennasar A, Riesco Prieto M, Fortuny Marqués R. Ther Drug Monit; 2009 Dec 01; 31(6):743-5. PubMed ID: 19935362 [Abstract] [Full Text] [Related]
15. Difference in blood tacrolimus concentration between ACMIA and MEIA in samples with low haematocrit values. Doki K, Homma M, Hori T, Tomita T, Hasegawa Y, Ito S, Fukunaga K, Kaneko M, Chiba S, Sumida T, Ohkohchi N, Kohda Y. J Pharm Pharmacol; 2010 Sep 01; 62(9):1185-8. PubMed ID: 20796198 [Abstract] [Full Text] [Related]
16. Calcineurin Inhibitor Determination in Whole Blood With the RXL Dimension Analyzer: A Useful Tool for Immunosuppressive Drug Monitoring. Ventura E, Bonardet A, Pageaux GP, Mourad G, Cristol JP. Transplant Proc; 2009 Mar 01; 41(2):707-9. PubMed ID: 19328963 [Abstract] [Full Text] [Related]
19. Inter-laboratory Variability of Current Immunoassay Methods for Tacrolimus among Japanese Hospitals. Miura M, Masuda S, Egawa H, Yuzawa K, Matsubara K. Biol Pharm Bull; 2016 Aug 01; 39(8):1331-7. PubMed ID: 27263473 [Abstract] [Full Text] [Related]
20. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods. Akbas SH, Ozdem S, Caglar S, Tuncer M, Gurkan A, Yucetin L, Senol Y, Demirbas A, Gultekin M, Ersoy FF, Akaydin M. Clin Biochem; 2005 Jun 01; 38(6):552-7. PubMed ID: 15885236 [Abstract] [Full Text] [Related] Page: [Next] [New Search]